Announcement on Voluntary Disclosure of MAT2A Inhibitor SY-9453 Obtaining the Notice of Approval for Drug Clinical Trials

About this update from Shouyao Holdings Beijing Co. Ltd. Class A

Announcement on Voluntary Disclosure of MAT2A Inhibitor SY-9453 Obtaining the Notice of Approval for Drug Clinical Trials The abstract is for reference only. Please refer to the full text of the announcement on the very day. Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Shouyao Holdings Beijing Co. Ltd. Class A